Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
Go back to Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 13.20 -0.54 (3.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.74 | 52 Week High | $5.58 | |||
| Open | $13.33 | 52 Week Low | $3.60 | |||
| Day High | $13.38 | P/E | N/A | |||
| Day Low | $13.15 | EPS | $0.00 | |||
| Volume | 7,405,879 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.37 -0.42 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.79 | 52 Week High | $44.76 | |||
| Open | $43.03 | 52 Week Low | $36.81 | |||
| Day High | $43.51 | P/E | N/A | |||
| Day Low | $42.88 | EPS | $0.00 | |||
| Volume | 1,466,973 | |||||
